MwanzoDMYD-B • STO
add
Diamyd Medical AB
Bei iliyotangulia
kr 17.30
Bei za siku
kr 16.68 - kr 17.88
Bei za mwaka
kr 7.50 - kr 17.88
Thamani ya kampuni katika soko
2.36B SEK
Wastani wa hisa zilizouzwa
elfu 598.91
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
STO
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (SEK) | Nov 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 245.00 | 842.31% |
Matumizi ya uendeshaji wa biashara | 48.14M | 15.02% |
Mapato halisi | -48.84M | -35.07% |
Kiwango cha faida halisi | elfu -19.94 | 85.67% |
Mapato kwa kila hisa | — | — |
EBITDA | -47.06M | -13.67% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (SEK) | Nov 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 233.18M | 52.53% |
Jumla ya mali | 302.46M | 35.70% |
Jumla ya dhima | 70.82M | 6.05% |
Jumla ya hisa | 231.64M | — |
hisa zilizosalia | 137.50M | — |
Uwiano wa bei na thamani | 10.30 | — |
Faida inayotokana na mali | -37.27% | — |
Faida inayotokana mtaji | -47.73% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (SEK) | Nov 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -48.84M | -35.07% |
Pesa kutokana na shughuli | -43.70M | -4.49% |
Pesa kutokana na uwekezaji | -20.10M | -183.55% |
Pesa kutokana na ufadhili | elfu 7.00 | -99.99% |
Mabadiliko halisi ya pesa taslimu | -63.85M | -259.15% |
Mtiririko huru wa pesa | -27.48M | 11.67% |
Kuhusu
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1984
Tovuti
Wafanyakazi
41
